Laura Meier - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Laura Meier

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Molecular Pharmaceutics|April 22, 2020

<i>In Vitro</i> Blood-Brain Barrier Permeability and Cytotoxicity of an Atorvastatin-Loaded Nanoformulation Against Glioblastoma in 2D and 3D ModelsMichael M Lübtow, Sabrina Oerter, Sabina Quader, et al.

Nature Communications|August 25, 2022

Designed peptides as nanomolar cross-amyloid inhibitors acting via supramolecular nanofiber co-assemblyKarin Taş, Beatrice Dalla Volta, Christina Lindner, et al.

BMJ Mental Health|August 21, 2025

Evidence for reduced synaptic protein SNAP-25 in cerebrospinal fluid in major depressive disorder and schizophreniaPetra Steinacker, Leonie Werner, Alexander Tarabuko, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Molecular Pharmaceutics|April 22, 2020

Nature Communications|August 25, 2022

Designed peptides as nanomolar cross-amyloid inhibitors acting via supramolecular nanofiber co-assemblyKarin Taş, Beatrice Dalla Volta, Christina Lindner, et al.

BMJ Mental Health|August 21, 2025

Evidence for reduced synaptic protein SNAP-25 in cerebrospinal fluid in major depressive disorder and schizophreniaPetra Steinacker, Leonie Werner, Alexander Tarabuko, et al.

Pageof 2